National and Kapodistrian University of Athens
Ο ρόλος των δενδριτικών κυττάρων στην αποδρομή της φλεγμονής σε πειραματικά μοντέλα αλλεργικού άσθματος
Abstract
dc:descriptionThis study involves the investigation of possible mechanisms that underlie allergic asthma, and specifically the allergic inflammation that characterizes the disease, and its exacerbations, mainly triggered by viral infections. Asthma is the most common noncommunicable respiratory disease and is characterized by chronic inflammation of the airways. Extensive research over the years has established the central role of type 2 immunity in the development of asthma, although the involvement of type 2 immunity in asthma exacerbations has been more complicated. Despite significant advances over the years in asthma management, acute exacerbations continue to occur, whereas, therapeutic interventions are still limited. Although, a plethora of immune cells has been associated with allergic inflammation that characterizes asthma, still a subtype of dendritic cells, plasmacytoid dendritic cells (pDCs), which until today is considered to play a significant role in antiviral immunity, suppression of inflammation and immunological tolerance in general, has not been studied extensively. The current study, suggests that pDCs, once they encounter an allergen of a virus, change their “immunoregulatory” phenotype and become “immunogenic” contributing to allergic responses during stable disease or during its exacerbations, and therefore, positions pDCs at the center of the immune-inflammatory process that drives allergic airway inflammation and asthma exacerbations with important therapeutic implications. More specifically, we show that pDCs are highly up-regulated in the sputum of patients with stable asthma and acute exacerbations of asthma compared to healthy individuals, and high pDC numbers correlate with augmented Th2 responses, more severe inflammation and increased likelihood for asthma attacks. Moreover, we demonstrate using animal models of allergic asthma and RV-induced exacerbations that pDCs are critically involved in driving the allergic response, both during stable disease and exacerbations Mechanistically, we identify IL-25 as a central mediator of pDC pro-inflammatory activation and migration, and establish the IL-25-pDC-driven axis as a major pathogenetic mechanism of asthma persistence and exacerbations. In summary, our study suggests that targeting pDCs or their upstream activator IL-25 constitutes a highly promising new strategy for treating difficult to control asthma, especially asthma exacerbations. It also advocates for the monitoring of pDCs in sputum as a novel way for diagnosing the severity of asthma and predicting the risk of exacerbations.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chairakaki, Aikaterini-Dimitra
- Χαιρακάκη, Αικατερίνη-Δήμητρα
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41148